Geode Capital Management
CPXX

Geode Capital Management’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Geode Capital Management’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-226,185
Closed -$6.83M – 4103
2016
Q2 		$6.83M Buy
226,185
+99,700
+79% +$2.02M ﹤0.01% 1692
2016
Q1 		$1.4K Buy
126,485
+59,470
+89% +$195K ﹤0.01% 2695
2015
Q4 		$117K Hold
67,015
– – ﹤0.01% 3847
2015
Q3 		$111K Buy
+67,015
New +$149K ﹤0.01% 3874

Geode Capital Management's CPXX Position: Q3 2016 in Review

Geode Capital Management sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 226,185 shares — an estimated $6.83M sold.

Geode Capital Management first reported a position in CPXX in Q3 2015 and held it in 4 quarters. The position peaked at $6.83M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Geode Capital Management reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Geode Capital Management sold 226,185 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $6.83M.
  • Geode Capital Management first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q3 2015 and held it in 4 quarters.
  • Geode Capital Management's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $6.83M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Geode Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.